货号:GS40807
Xentuzumab (BI 836845) is an investigational humanized monoclonal antibody that targets and neutralizes insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 2 (IGF-2). It is being developed for the treatment of advanced solid tumors, particularly in combination with other therapies, aiming to inhibit the IGF signaling pathway which is often dysregulated in cancer and promotes tumor growth and survival.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯